Cas:148583-59-9 1-(2,6-dimethoxyphenyl)piperazine manufacturer & supplier

We serve Chemical Name:1-(2,6-dimethoxyphenyl)piperazine CAS:148583-59-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(2,6-dimethoxyphenyl)piperazine

Chemical Name:1-(2,6-dimethoxyphenyl)piperazine
CAS.NO:148583-59-9
Synonyms:MFCD03426029
Molecular Formula:C12H18N2O2
Molecular Weight:222.28400
HS Code:

Physical and Chemical Properties:
Melting point:35ºC
Boiling point:375.4ºC at 760 mmHg
Density:1.08g/cm3
Index of Refraction:1.526
PSA:33.73000
Exact Mass:222.13700
LogP:1.50720

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3259
Packing Group:III


Contact us for information like MFCD03426029 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03426029 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD03426029 Use and application,MFCD03426029 technical grade,usp/ep/jp grade.


Related News: Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. 1-(2,6-dimethoxyphenyl)piperazine manufacturer Slow business: Due to fear — and travel warnings — fewer people want to travel to China. 1-(2,6-dimethoxyphenyl)piperazine supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 1-(2,6-dimethoxyphenyl)piperazine vendor Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. 1-(2,6-dimethoxyphenyl)piperazine factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.